Treatment of Insomnia by Zopiclone in Older Adults Hospitalized in a Geriatric Hospital: A Retrospective Study
Helena Lebreton1, Nadia Ladjouzi2, Hendriniaina Raveloson2, Diana Lopez-Leret3, Joël Schlatter3★★ Corresponding author
- 1Long-term Care Unit, Assistance Publique des Hôpitaux de Paris, Hôpital Paul Doumer, Labruyère, FRANCE.
- 2Acute Geriatric Medicine Unit, Assistance Publique des Hôpitaux de Paris, Hôpital Paul Doumer, Labruyère, FRANCE.
- 3Department of Pharmacy, Assistance Publique des Hôpitaux de Paris, Hôpital Paul Doumer, Labruyère, FRANCE.
CORRESPONDENCE
Joël Schlatter
Department of Pharmacy, Assistance Publique des Hôpitaux de Paris, Hôpital Paul Doumer, Labruyère, FRANCE.
Received: 27-03-2024; Revised: 24-07-2024; Accepted: 05-08-2024.
Volume 16, Issue 3 · pp. 337–341 · PUBLISHED 2025 · DOI: 10.1177/0976500X251314602
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Background: Insomnia is a significant public health problem that can affect up to 50% of older adults. Pharmacological treatments are commonly used such as benzodiazepines (BZD) and related Z-drug zopiclone. Objectives: The objective of this study was to investigate the use of zopiclone under real-life clinical conditions. Materials and Methods: A retrospective review of older patients was conducted in a French geriatric hospital. The eligible participants included patients aged 65 years and older who had received zopiclone as a hypnotic. The presence of indication, the dosage and duration of zopiclone, the reevaluation of the treatment, the reason for discontinuation, and the combination with BZD were assessed. Results: The study included 30 subjects (mean age 84.6 ± 9.3 years), 90% of whom received zopiclone 3.5 mg and 10% zopiclone 7.5 mg. In 60% of cases, no indication of insomnia was found. At discharge, more patients received a combination of zopiclone and BZD. The drug reassessment was initiated in only nine patients. Conclusion: The treatment of insomnia with zopiclone is usually prescribed for long-term periods in older adults with less need for reevaluation. More long-term data on side effects and therapeutic efficacy are needed in routine clinical practice.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Lebreton, H., Ladjouzi, N., Raveloson, H., Lopez-Leret, D., & Schlatter, J. (2025). Treatment of Insomnia by Zopiclone in Older Adults Hospitalized in a Geriatric Hospital: A Retrospective Study. Journal of Pharmacology and Pharmacotherapeutics, 16(3), 337–341. https://doi.org/10.1177/0976500X251314602
